Site Selection: a Case Study in the Identification of Optimal Cysteine Engineered Antibody Drug Conjugates

Volume: 19, Issue: 4, Pages: 1123 - 1135
Published: Apr 24, 2017
Abstract
As the antibody drug conjugate (ADC) community continues to shift towards site-specific conjugation technology, there is a growing need to understand how the site of conjugation impacts the biophysical and biological properties of an ADC. In order to address this need, we prepared a carefully selected series of engineered cysteine ADCs and proceeded to systematically evaluate their potency, stability, and PK exposure. The site of conjugation did...
Paper Details
Title
Site Selection: a Case Study in the Identification of Optimal Cysteine Engineered Antibody Drug Conjugates
Published Date
Apr 24, 2017
Volume
19
Issue
4
Pages
1123 - 1135
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.